By Tom Angell | Forbes
The Trump administration is asking the public to submit comments to help inform the U.S.’s position on the potential global reclassification of marijuana.
Last month, the World Health Organization (WHO) formally recommended that cannabis and its derivatives be rescheduled under international drug treaties.
Now, the U.S. Food and Drug Administration (FDA) wants “interested persons to submit comments on the notifications from the United Nations concerning these drug substances,” Lowell J. Schiller, FDA’s acting associate commissioner for policy, wrote in a notice published in the Federal Register on Friday.
“The FDA is seeking input from the public on the World Health Organization’s recent cannabis rescheduling recommendations. These comments could help shape the United States’ UN representatives position when international reclassification decision comes to a vote as soon as this month. A shift in global scheduling policy could have a major impact on the legal cannabis industry at home and abroad.”
